Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin versus levofloxacin triple therapy for Helicobacter pylori eradication
PACTR202012742050337Phase 3Completed
- Sponsor
- Benha University Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of clarithromycin, levofloxacin, amoxicillin and esomeprazole in Helicobacter pylori infection (2 arms), sponsored by Benha University Hospital. Primary endpoint: Cure confirmed by negative Helicobacter pylori stool antigen. Started Dec 2020; status: completed.
02
Drugs
clarithromycinlevofloxacinamoxicillinesomeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on PACTR202012742050337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202012742050337.